RT Journal Article
SR Electronic
T1 Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008677
DO 10.1136/jitc-2023-008677
VO 12
IS 7
A1 Willoughby, Jane E
A1 Dou, Lang
A1 Bhattacharya, Sabyasachi
A1 Jackson, Heather
A1 Seestaller-Wehr, Laura
A1 Kilian, David
A1 Bover, Laura
A1 Voo, Kui S
A1 Cox, Kerry L
A1 Murray, Tom
A1 John, Mel
A1 Shi, Hong
A1 Bojczuk, Paul
A1 Jing, Junping
A1 Niederer, Heather
A1 Shepherd, Andrew J
A1 Hook, Laura
A1 Hopley, Stephanie
A1 Inzhelevskaya, Tatyana
A1 Penfold, Chris A
A1 Mockridge, C Ian
A1 English, Vikki
A1 Brett, Sara J
A1 Srinivasan, Roopa
A1 Hopson, Christopher
A1 Smothers, James
A1 Hoos, Axel
A1 Paul, Elaine
A1 Martin, Stephen L
A1 Morley, Peter J
A1 Yanamandra, Niranjan
A1 Cragg, Mark S
YR 2024
UL http://jitc.bmj.com/content/12/7/e008677.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.